Author:
Mertens Nathalie,Schmidt Mark E.,Hijzen Anja,Van Weehaeghe Donatienne,Ravenstijn Paulien,Depre Marleen,de Hoon Jan,Van Laere Koen,Koole Michel
Abstract
Abstract[18F]JNJ-64413739 has been evaluated as PET-ligand for in vivo quantification of purinergic receptor subtype 7 receptor (P2X7R) using Logan graphical analysis with a metabolite-corrected arterial plasma input function. In the context of a P2X7R PET dose occupancy study, we evaluated a minimally invasive approach by limiting arterial sampling to baseline conditions. Meanwhile, post dose distribution volumes (VT) under blocking conditions were estimated by combining baseline blood to plasma ratios and metabolite fractions with an MR angiography driven image derived input function (IDIF). Regional postdose VT,IDIF values were compared with corresponding VT,AIF estimates using a arterial input function (AIF), in terms of absolute values, test–retest reliability and receptor occupancy. Compared to an invasive AIF approach, postdose VT,IDIF values and corresponding receptor occupancies showed only limited bias (Bland–Altman analysis: 0.06 ± 0.27 and 3.1% ± 6.4%) while demonstrating a high correlation (Spearman ρ = 0.78 and ρ = 0.98 respectively). In terms of test–retest reliability, regional intraclass correlation coefficients were 0.98 ± 0.02 for VT,IDIF compared to 0.97 ± 0.01 for VT,AIF. These results confirmed that a postdose IDIF, guided by MR angiography and using baseline blood and metabolite data, can be considered for accurate [18F]JNJ-64413739 PET quantification in a repeated PET study design, thus avoiding multiple invasive arterial sampling and increasing dosing flexibility.
Funder
Fund for Scientific Research, Belgium
Publisher
Springer Science and Business Media LLC
Reference39 articles.
1. Wei, L. et al. ATP-activated P2X7 receptor in the pathophysiology of mood disorders and as an emerging target for the development of novel antidepressant therapeutics. Neurosci. Biobehav. Rev. 87, 192–205 (2018).
2. Mortaz, E., Adcock, I. M., Shafei, H., Masjedi, M. R. & Folkerts, G. Role of P2X7 receptors in release of IL-1β: A possible mediator of pulmonary inflammation. Tanaffos 11, 6–11 (2012).
3. Eyo, U. B., Miner, S. A., Ahlers, K. E., Wu, L. J. & Dailey, M. E. P2X7 receptor activation regulates microglial cell death during oxygen-glucose deprivation. Neuropharmacology 73, 311–319 (2013).
4. Takenouchi, T. et al. P2X7 Receptor signaling pathway as a therapeutic target for neurodegenerative diseases. Arch. Immunol. Ther. Exp. 58, 91–96 (2010).
5. Apolloni, S. et al. Spinal cord pathology is ameliorated by P2X7 antagonism in a SOD1-mutant mouse model of amyotrophic lateral sclerosis. Dis. Model. Mech. 7, 1101–1109 (2014).
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献